8ILR
Cryo-EM structure of PI3Kalpha in complex with compound 16
8ILR の概要
エントリーDOI | 10.2210/pdb8ilr/pdb |
EMDBエントリー | 35543 |
分子名称 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform, Phosphatidylinositol 3-kinase regulatory subunit alpha, N-[(2S)-1-(ethylamino)-1-oxidanylidene-3-[4-(2-quinoxalin-6-ylethynyl)phenyl]propan-2-yl]-2,3-dimethyl-quinoxaline-6-carboxamide, ... (4 entities in total) |
機能のキーワード | phosphoinositide 3-kinase, drug target, ligand, binding pocket, chemical scaffold, structural protein |
由来する生物種 | Homo sapiens (human) 詳細 |
タンパク質・核酸の鎖数 | 2 |
化学式量合計 | 211974.38 |
構造登録者 | Zhou, Q.,Liu, X.,Neri, D.,Li, W.,Favalli, N.,Bassi, G.,Yang, S.,Yang, D.,Vogt, P.K.,Wang, M.-W. (登録日: 2023-03-04, 公開日: 2023-08-30) |
主引用文献 | Zhou, Q.,Liu, X.,Neri, D.,Li, W.,Favalli, N.,Bassi, G.,Yang, S.,Yang, D.,Vogt, P.K.,Wang, M.W. Structural insights into the interaction of three Y-shaped ligands with PI3K alpha. Proc.Natl.Acad.Sci.USA, 120:e2304071120-e2304071120, 2023 Cited by PubMed Abstract: Class IA phosphoinositide 3-kinase alpha (PI3Kα) is an important drug target because it is one of the most frequently mutated proteins in human cancers. However, small molecule inhibitors currently on the market or under development have safety concerns due to a lack of selectivity. Therefore, other chemical scaffolds or unique mechanisms of catalytic kinase inhibition are needed. Here, we report the cryo-electron microscopy structures of wild-type PI3Kα, the dimer of p110α and p85α, in complex with three Y-shaped ligands [cpd16 (compound 16), cpd17 (compound 17), and cpd18 (compound 18)] of different affinities and no inhibitory effect on the kinase activity. Unlike ATP-competitive inhibitors, cpd17 adopts a Y-shaped conformation with one arm inserted into a binding pocket formed by R770 and W780 and the other arm lodged in the ATP-binding pocket at an angle that is different from that of the ATP phosphate tail. Such a special interaction induces a conformation of PI3Kα resembling that of the unliganded protein. These observations were confirmed with two isomers (cpd16 and cpd18). Further analysis of these Y-shaped ligands revealed the structural basis of differential binding affinities caused by stereo- or regiochemical modifications. Our results may offer a different direction toward the design of therapeutic agents against PI3Kα. PubMed: 37585458DOI: 10.1073/pnas.2304071120 主引用文献が同じPDBエントリー |
実験手法 | ELECTRON MICROSCOPY (3.05 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード